Insider · CIK 0002077001

Boyd Matthew Ross

Reports to the SEC for 1 company · SAINT-LAURENT, A8

Transactions

Companies

Filings

CIK

0002077001

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-30	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Regulatory Officer	AAward	+195K sh	—	—	195,000
2025-07-08	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Regulatory Officer	AAward	+100K sh	—	—	100,000

C/O 4868 RUE LEVY, SUITE 220

SAINT-LAURENT, A8, H4R 2P1